These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28269445)

  • 1. Understanding the cochlear implant environment by mapping perilymph proteomes from different species.
    Palmer JC; Lord MS; Pinyon JL; Wise AK; Lovell NH; Carter PM; Enke YL; Housley GD; Green RA
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():5237-5240. PubMed ID: 28269445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing perilymph proteomes across species.
    Palmer JC; Lord MS; Pinyon JL; Wise AK; Lovell NH; Carter PM; Enke YL; Housley GD; Green RA
    Laryngoscope; 2018 Jan; 128(1):E47-E52. PubMed ID: 29094758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome profile of patients with excellent and poor speech intelligibility after cochlear implantation: Can perilymph proteins predict performance?
    Durisin M; Krüger C; Pich A; Warnecke A; Steffens M; Zeilinger C; Lenarz T; Prenzler N; Schmitt H
    PLoS One; 2022; 17(3):e0263765. PubMed ID: 35239655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo electrochemical monitoring of the change of cochlear perilymph ascorbate during salicylate-induced tinnitus.
    Liu J; Yu P; Lin Y; Zhou N; Li T; Ma F; Mao L
    Anal Chem; 2012 Jun; 84(12):5433-8. PubMed ID: 22703231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo pharmacokinetic study of a dexamethasone-releasing silicone for cochlear implants.
    Liu Y; Jolly C; Braun S; Stark T; Scherer E; Plontke SK; Kiefer J
    Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1745-53. PubMed ID: 26319276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth proteome of perilymph in guinea pig model.
    Lee JH; Hwang YJ; Li H; Kim H; Suh MW; Han D; Oh SH
    Proteomics; 2021 Mar; 21(5):e2000138. PubMed ID: 33459488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefuroxime: pharmacokinetics in cochlear perilymph, cerebrospinal fluid, and plasma.
    Sun AH; Parnes LS; Freeman DJ
    J Otolaryngol; 1995 Apr; 24(2):134-7. PubMed ID: 7602674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of systemic and local dexamethasone administration: From perilymph/cochlea concentration to cochlear distribution.
    Wang Y; Han L; Diao T; Jing Y; Wang L; Zheng H; Ma X; Qi J; Yu L
    Hear Res; 2018 Dec; 370():1-10. PubMed ID: 30223171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome of human perilymph.
    Lysaght AC; Kao SY; Paulo JA; Merchant SN; Steen H; Stankovic KM
    J Proteome Res; 2011 Sep; 10(9):3845-51. PubMed ID: 21740021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An LCMS-based untargeted metabolomics protocol for cochlear perilymph: highlighting metabolic effects of hydrogen gas on the inner ear of noise exposed Guinea pigs.
    Pirttilä K; Videhult Pierre P; Haglöf J; Engskog M; Hedeland M; Laurell G; Arvidsson T; Pettersson C
    Metabolomics; 2019 Oct; 15(10):138. PubMed ID: 31587113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of BDNF-Related Proteins in Human Perilymph in Patients With Hearing Loss.
    de Vries I; Schmitt H; Lenarz T; Prenzler N; Alvi S; Staecker H; Durisin M; Warnecke A
    Front Neurosci; 2019; 13():214. PubMed ID: 30971872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlear pharmacokinetics of cisplatin: an in vivo study in the guinea pig.
    Hellberg V; Wallin I; Ehrsson H; Laurell G
    Laryngoscope; 2013 Dec; 123(12):3172-7. PubMed ID: 23754209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perilymph pharmacokinetics of marker applied through a cochlear implant in guinea pigs.
    Salt A; Hartsock J; Gill R; Smyth D; Kirk J; Verhoeven K
    PLoS One; 2017; 12(8):e0183374. PubMed ID: 28817653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and performance of a biomimetic artificial perilymph for in vitro testing of medical devices.
    Palmer JC; Green RA; Boscher F; Poole-Warren LA; Carter PM; Enke YL; Lovell NH; Lord MS
    J Neural Eng; 2019 Apr; 16(2):026006. PubMed ID: 30523975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Neurotrophin Signaling Using MicroRNA Perilymph Profiling in Cochlear Implant Patients With and Without Residual Hearing.
    Shew M; Wichova H; Warnecke A; Lenarz T; Staecker H
    Otol Neurotol; 2021 Sep; 42(8):e1125-e1133. PubMed ID: 33973949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a dexamethasone-releasing implant on cochleae: A functional, morphological and pharmacokinetic study.
    Liu Y; Jolly C; Braun S; Janssen T; Scherer E; Steinhoff J; Ebenhoch H; Lohner A; Stark T; Kiefer J
    Hear Res; 2015 Sep; 327():89-101. PubMed ID: 25987502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat Shock Proteins in Human Perilymph: Implications for Cochlear Implantation.
    Schmitt H; Roemer A; Zeilinger C; Salcher R; Durisin M; Staecker H; Lenarz T; Warnecke A
    Otol Neurotol; 2018 Jan; 39(1):37-44. PubMed ID: 29227447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome of normal human perilymph and perilymph from people with disabling vertigo.
    Lin HC; Ren Y; Lysaght AC; Kao SY; Stankovic KM
    PLoS One; 2019; 14(6):e0218292. PubMed ID: 31185063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perilymph composition in scala tympani of the cochlea: influence of cerebrospinal fluid.
    Hara A; Salt AN; Thalmann R
    Hear Res; 1989 Nov; 42(2-3):265-71. PubMed ID: 2606807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perilymph sampling from the cochlear apex: a reliable method to obtain higher purity perilymph samples from scala tympani.
    Salt AN; Hale SA; Plonkte SK
    J Neurosci Methods; 2006 May; 153(1):121-9. PubMed ID: 16310856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.